# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-096760
Filing Date
2025-04-25
Accepted
2025-04-25 16:08:32
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d898137ddefa14a.htm | DEFA14A | 12016
2 | GRAPHIC | g898137g01g01.jpg | GRAPHIC | 341058
3 | GRAPHIC | g898137g02g02.jpg | GRAPHIC | 283355
| Complete submission text file | 0001193125-25-096760.txt |  | 873345

Mailing Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209
Business Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37415 | Film No.: 25873986
SIC: 8741 Services-Management Services
(CF Office: 07 Trade & Services)